{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T06:29:02Z","timestamp":1791872942663,"version":"4.3.4"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82001738"],"award-info":[{"award-number":["82001738"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82003363"],"award-info":[{"award-number":["82003363"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073449"],"award-info":[{"award-number":["82073449"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82203930"],"award-info":[{"award-number":["82203930"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82203932"],"award-info":[{"award-number":["82203932"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011790","name":"Xiangya Hospital, Central South University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011790","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.intimp.2023.110420","type":"journal-article","created":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T04:34:28Z","timestamp":1686890068000},"page":"110420","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["ATRA ameliorates fibrosis by suppressing the pro-fibrotic molecule Fra2\/AP-1 in systemic sclerosis"],"prefix":"10.1016","volume":"121","author":[{"given":"Zixin","family":"Pi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiani","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangfan","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinglan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruixuan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangning","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuotong","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqian","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6214-8057","authenticated-orcid":false,"given":"Rong","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2023.110420_b0005","doi-asserted-by":"crossref","DOI":"10.1007\/s12016-021-08889-8","article-title":"Current concepts on the pathogenesis of systemic sclerosis","author":"Truchetet","year":"2021","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"10","key":"10.1016\/j.intimp.2023.110420_b0010","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/s41584-021-00683-2","article-title":"Advances in epigenetics in systemic sclerosis: molecular mechanisms and therapeutic potential","volume":"17","author":"Tsou","year":"2021","journal-title":"Nat. Rev. Rheumatol."},{"issue":"12","key":"10.1016\/j.intimp.2023.110420_b0015","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/s41584-019-0322-7","article-title":"Shared and distinct mechanisms of fibrosis","volume":"15","author":"Distler","year":"2019","journal-title":"Nat. Rev. Rheumatol."},{"issue":"5","key":"10.1016\/j.intimp.2023.110420_b0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111147","article-title":"AP-1 transcription factor network explains diverse patterns of cellular plasticity in melanoma cells","volume":"40","author":"Comandante-Lou","year":"2022","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.intimp.2023.110420_b0025","first-page":"11","article-title":"The AP-1 transcriptional complex: local switch or remote command?","volume":"1872","author":"Bejjani","year":"2019","journal-title":"BBA"},{"key":"10.1016\/j.intimp.2023.110420_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2019.109408","article-title":"Transcription factor Fra-2 and its emerging role in matrix deposition, proliferation and inflammation in chronic lung diseases","volume":"64","author":"Birnhuber","year":"2019","journal-title":"Cell. Signal."},{"issue":"8","key":"10.1016\/j.intimp.2023.110420_b0035","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1136\/annrheumdis-2011-200940","article-title":"Fra-2 transgenic mice as a novel model of pulmonary hypertension associated with systemic sclerosis","volume":"71","author":"Maurer","year":"2012","journal-title":"Ann. Rheum. Dis."},{"issue":"13","key":"10.1016\/j.intimp.2023.110420_b0040","doi-asserted-by":"crossref","DOI":"10.1242\/dev.167502","article-title":"Retinoic acid signaling pathways","volume":"146","author":"Ghyselinck","year":"2019","journal-title":"Development"},{"issue":"9","key":"10.1016\/j.intimp.2023.110420_b0045","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1007\/s00018-010-0268-z","article-title":"From carrot to clinic: an overview of the retinoic acid signaling pathway","volume":"67","author":"Theodosiou","year":"2010","journal-title":"Cell. Mol. Life Sci."},{"issue":"1","key":"10.1016\/j.intimp.2023.110420_b0050","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/14656566.2021.1961744","article-title":"Drug treatment options for acute promyelocytic leukemia","volume":"23","author":"Ferrara","year":"2022","journal-title":"Expert Opin. Pharmacother."},{"issue":"2","key":"10.1016\/j.intimp.2023.110420_b0055","doi-asserted-by":"crossref","DOI":"10.3390\/biom12020200","article-title":"Retinoic acid grafted to hyaluronic acid activates retinoid gene expression and removes cholesterol from cellular membranes","volume":"12","author":"Pavl\u00edk","year":"2022","journal-title":"Biomolecules"},{"issue":"3","key":"10.1016\/j.intimp.2023.110420_b0060","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s40257-021-00594-8","article-title":"50 years of topical retinoids for acne: evolution of treatment","volume":"22","author":"Baldwin","year":"2021","journal-title":"Am. J. Clin. Dermatol."},{"issue":"3","key":"10.1016\/j.intimp.2023.110420_b0065","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1182\/blood.2021013393","article-title":"All-trans retinoic acid plus low-dose rituximab vs low-dose rituximab in corticosteroid-resistant or relapsed ITP","volume":"139","author":"Wu","year":"2022","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.intimp.2023.110420_b0070","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1001\/jamaoncol.2021.5206","article-title":"Assessment of arsenic trioxide and all-trans retinoic acid for the treatment of pediatric acute promyelocytic leukemia: a report from the children's oncology group AAML1331 trial","volume":"8","author":"Kutny","year":"2022","journal-title":"JAMA Oncol."},{"issue":"9","key":"10.1016\/j.intimp.2023.110420_b0075","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1111\/j.1478-3231.2008.01745.x","article-title":"All-trans-retinoic acid ameliorates carbon tetrachloride-induced liver fibrosis in mice through modulating cytokine production","volume":"28","author":"Hisamori","year":"2008","journal-title":"Liver Int.: Official J. Int. Association Study Liver"},{"issue":"10","key":"10.1016\/j.intimp.2023.110420_b0080","doi-asserted-by":"crossref","DOI":"10.3390\/biom9100525","article-title":"All-trans retinoic acid attenuates fibrotic processes by downregulating TGF-\u03b21\/Smad3 in early diabetic nephropathy","volume":"9","author":"Sierra-Mondragon","year":"2019","journal-title":"Biomolecules"},{"issue":"3","key":"10.1016\/j.intimp.2023.110420_b0085","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.bbrc.2017.07.122","article-title":"All-trans retinoic acid attenuates bleomycin-induced pulmonary fibrosis via downregulating EphA2-EphrinA1 signaling","volume":"491","author":"Leem","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.intimp.2023.110420_b0090","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1346-8138.2010.00993.x","article-title":"Retinoic acids exhibit anti-fibrotic activity through the inhibition of 5-lipoxygenase expression in scleroderma fibroblasts","volume":"38","author":"Xiao","year":"2011","journal-title":"J. Dermatol."},{"issue":"4","key":"10.1016\/j.intimp.2023.110420_b0095","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1365-2230.2008.02727.x","article-title":"9-Cis-retinoic acid exhibits antifibrotic activity via the induction of cyclooxygenase-2 expression and prostaglandin E2 production in scleroderma fibroblasts","volume":"33","author":"Xiao","year":"2008","journal-title":"Clin. Exp. Dermatol."},{"issue":"11","key":"10.1016\/j.intimp.2023.110420_b0100","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","article-title":"2013 classification criteria for systemic sclerosis: an American college of rheumatology\/European league against rheumatism collaborative initiative","volume":"72","author":"van den Hoogen","year":"2013","journal-title":"Ann. Rheum. Dis."},{"issue":"12","key":"10.1016\/j.intimp.2023.110420_b0105","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1631\/jzus.B1900271","article-title":"All-trans-retinoic acid generation is an antidotal clearance pathway for all-trans-retinal in the retina","volume":"20","author":"Xia","year":"2019","journal-title":"J. Zhejiang Univ. Sci. B"},{"issue":"24","key":"10.1016\/j.intimp.2023.110420_b0110","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.144935","article-title":"E4 engages uPAR and enolase-1 and activates urokinase to exert antifibrotic effects","volume":"6","author":"Sharma","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.intimp.2023.110420_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106057","article-title":"Esomeprazole alleviates fibrosis in systemic sclerosis by modulating AhR\/Smad2\/3 signaling","volume":"176","author":"Liu","year":"2022","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.intimp.2023.110420_b0120","doi-asserted-by":"crossref","first-page":"4451","DOI":"10.1038\/s41598-021-83939-x","article-title":"All-trans-retinoic acid ameliorates atherosclerosis, promotes perivascular adipose tissue browning, and increases adiponectin production in Apo-E mice","volume":"11","author":"Kalisz","year":"2021","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.intimp.2023.110420_b0125","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/jcp.20972","article-title":"Therapies for bleomycin induced lung fibrosis through regulation of TGF-beta1 induced collagen gene expression","volume":"211","author":"Cutroneo","year":"2007","journal-title":"J. Cell. Physiol."},{"issue":"1","key":"10.1016\/j.intimp.2023.110420_b0130","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s13075-022-02773-2","article-title":"The compound LG283 inhibits bleomycin-induced skin fibrosis via antagonizing TGF-\u03b2 signaling","volume":"24","author":"Utsunomiya","year":"2022","journal-title":"Arthritis Res. Ther."},{"issue":"8","key":"10.1016\/j.intimp.2023.110420_b0135","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.1172\/JCI125366","article-title":"Fra-2-expressing macrophages promote lung fibrosis in mice","volume":"129","author":"Ucero","year":"2019","journal-title":"J. Clin. Invest."},{"issue":"Pt 1","key":"10.1016\/j.intimp.2023.110420_b0140","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1242\/jcs.102.1.113","article-title":"Retinoic acid receptor expression in human skin keratinocytes and dermal fibroblasts in vitro","volume":"102","author":"Redfern","year":"1992","journal-title":"J. Cell Sci."},{"issue":"4","key":"10.1016\/j.intimp.2023.110420_b0145","doi-asserted-by":"crossref","DOI":"10.2144\/000112729","article-title":"Standardized quantification of pulmonary fibrosis in histological samples","volume":"44","author":"H\u00fcbner","year":"2008","journal-title":"Biotechniques"},{"issue":"30","key":"10.1016\/j.intimp.2023.110420_b0150","doi-asserted-by":"crossref","first-page":"10525","DOI":"10.1073\/pnas.0801414105","article-title":"Development of pulmonary fibrosis through a pathway involving the transcription factor Fra-2\/AP-1","volume":"105","author":"Eferl","year":"2008","journal-title":"PNAS"},{"key":"10.1016\/j.intimp.2023.110420_b0155","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.3389\/fimmu.2018.02018","article-title":"Fra2 overexpression in mice leads to non-allergic asthma development in an IL-13 dependent manner","volume":"9","author":"Gungl","year":"2018","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2023.110420_b0160","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1093\/cvr\/cvq123","article-title":"Fra-2 mediates oxygen-sensitive induction of transforming growth factor beta in cardiac fibroblasts","volume":"87","author":"Roy","year":"2010","journal-title":"Cardiovasc. Res."},{"issue":"1","key":"10.1016\/j.intimp.2023.110420_b0165","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/art.25056","article-title":"The transcription factor Fra-2 regulates the production of extracellular matrix in systemic sclerosis","volume":"62","author":"Reich","year":"2010","journal-title":"Arthritis Rheum."},{"issue":"6","key":"10.1016\/j.intimp.2023.110420_b0170","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1083\/jcb.201002111","article-title":"Fra-2\/AP-1 controls bone formation by regulating osteoblast differentiation and collagen production","volume":"190","author":"Bozec","year":"2010","journal-title":"J. Cell Biol."},{"issue":"4","key":"10.1016\/j.intimp.2023.110420_b0175","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1046\/j.1523-1747.1999.00528.x","article-title":"Animal model of sclerotic skin. I: Local injections of bleomycin induce sclerotic skin mimicking scleroderma","volume":"112","author":"Yamamoto","year":"1999","journal-title":"J, Invest. Dermatol."},{"key":"10.1016\/j.intimp.2023.110420_b0180","doi-asserted-by":"crossref","unstructured":"T. Yamamoto, K. Nishioka, Animal model of sclerotic skin. V: Increased expression of alpha-smooth muscle actin in fibroblastic cells in bleomycin-induced scleroderma, Clin. Immunol. (Orlando, Fla) 102 (1) (2002) 77\u201383.","DOI":"10.1006\/clim.2001.5138"},{"issue":"7","key":"10.1016\/j.intimp.2023.110420_b0185","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1164\/rccm.200505-717OC","article-title":"Pharmacologic differentiation of inflammation and fibrosis in the rat bleomycin model","volume":"173","author":"Chaudhary","year":"2006","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"2","key":"10.1016\/j.intimp.2023.110420_b0190","doi-asserted-by":"crossref","first-page":"L152","DOI":"10.1152\/ajplung.00313.2007","article-title":"Murine models of pulmonary fibrosis","volume":"294","author":"Moore","year":"2008","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.intimp.2023.110420_b0195","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.phrs.2015.04.012","article-title":"Bleomycin in the setting of lung fibrosis induction: from biological mechanisms to counteractions","volume":"97","author":"Della Latta","year":"2015","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.intimp.2023.110420_b0200","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/978-1-4939-7113-8_2","article-title":"The bleomycin model of pulmonary fibrosis","volume":"1627","author":"Liu","year":"2017","journal-title":"Methods Mol. Biol. (Clifton, NJ)"},{"issue":"3","key":"10.1016\/j.intimp.2023.110420_b0205","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1111\/cts.12962","article-title":"Altered vitamin A metabolism in human liver slices corresponds to fibrogenesis","volume":"14","author":"Czuba","year":"2021","journal-title":"Clin. Transl. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2023.110420_b0210","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/jcp.25921","article-title":"All-trans retinoic acid ameliorates hepatic stellate cell activation via suppression of thioredoxin interacting protein expression","volume":"233","author":"Shimizu","year":"2018","journal-title":"J. Cell. Physiol."},{"issue":"1","key":"10.1016\/j.intimp.2023.110420_b0215","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1080\/0886022X.2021.1910046","article-title":"All-trans retinoic acid regulating angiopoietins-1 and alleviating extracellular matrix accumulation in interstitial fibrosis rats","volume":"43","author":"Zhong","year":"2021","journal-title":"Ren. Fail."},{"key":"10.1016\/j.intimp.2023.110420_b0220","doi-asserted-by":"crossref","first-page":"8658156","DOI":"10.1155\/2018\/8658156","article-title":"All-trans retinoic acid induces CD4+CD25+FOXP3+ regulatory T cells by increasing FOXP3 demethylation in systemic sclerosis CD4+ T cells","volume":"2018","author":"Sun","year":"2018","journal-title":"J. Immunol. Res."},{"issue":"12","key":"10.1016\/j.intimp.2023.110420_b0225","doi-asserted-by":"crossref","DOI":"10.3390\/cells9122660","article-title":"Retinoic acid and its derivatives in skin","volume":"9","author":"Szyma\u0144ski","year":"2020","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.intimp.2023.110420_b0230","doi-asserted-by":"crossref","DOI":"10.3390\/cells11030322","article-title":"Towards a better vision of retinoic acid signaling during eye development","volume":"11","author":"Duester","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.intimp.2023.110420_b0235","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1146\/annurev-nutr-082018-124228","article-title":"Vitamin A and Vitamin E: will the real antioxidant please stand up?","volume":"41","author":"Blaner","year":"2021","journal-title":"Annu. Rev. Nutr."},{"issue":"3","key":"10.1016\/j.intimp.2023.110420_b0240","doi-asserted-by":"crossref","first-page":"E418","DOI":"10.1152\/ajpendo.00218.2018","article-title":"All-trans retinoic acid suppresses bone morphogenetic protein 4 in mouse diabetic nephropathy through a unique retinoic acid response element","volume":"316","author":"Tamaki","year":"2019","journal-title":"Am. J. Phys. Endocrinol. Metab."},{"key":"10.1016\/j.intimp.2023.110420_b0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.174822","article-title":"ATRA promotes PD-L1 expression to control gastric cancer immune surveillance","volume":"920","author":"Ma","year":"2022","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.intimp.2023.110420_b0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113451","article-title":"Overview of all-trans-retinoic acid (ATRA) and its analogues: Structures, activities, and mechanisms in acute promyelocytic leukaemia","volume":"220","author":"Liang","year":"2021","journal-title":"Eur. J. Med. Chem."},{"issue":"12","key":"10.1016\/j.intimp.2023.110420_b0255","first-page":"3271","article-title":"Unique anti-activator protein-1 activity of retinoic acid receptor beta","volume":"60","author":"Lin","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.intimp.2023.110420_b0260","doi-asserted-by":"crossref","unstructured":"R. Sch\u00fcle, P. Rangarajan, N. Yang, S. Kliewer, L.J. Ransone, J. Bolado, et al., Retinoic acid is a negative regulator of AP-1-responsive genes, Proc. Natl. Acad. Sci. U. S. A. 88 (14) (1991) 6092\u20136096.","DOI":"10.1073\/pnas.88.14.6092"},{"issue":"2","key":"10.1016\/j.intimp.2023.110420_b0265","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/(SICI)1097-4652(199611)169:2<320::AID-JCP11>3.0.CO;2-D","article-title":"Inhibition of rabbit collagenase (matrix metalloproteinase-1; MMP-1) transcription by retinoid receptors: evidence for binding of RARs\/RXRs to the -77 AP-1 site through interactions with c-Jun","volume":"169","author":"Schroen","year":"1996","journal-title":"J. Cell. Physiol."},{"issue":"2","key":"10.1016\/j.intimp.2023.110420_b0270","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1177\/096032719501400214","article-title":"The ying-yang of RAR and AP-1: cancer treatment without overt toxicity","volume":"14","author":"Allenby","year":"1995","journal-title":"Hum. Exp. Toxicol."},{"issue":"4","key":"10.1016\/j.intimp.2023.110420_b0275","first-page":"689","article-title":"fra-2 promoter can respond to serum-stimulation through AP-1 complexes","volume":"10","author":"Sonobe","year":"1995","journal-title":"Oncogene"},{"issue":"42","key":"10.1016\/j.intimp.2023.110420_b0280","doi-asserted-by":"crossref","first-page":"6434","DOI":"10.1038\/sj.onc.1205822","article-title":"Menin uncouples Elk-1, JunD and c-Jun phosphorylation from MAP kinase activation","volume":"21","author":"Gallo","year":"2002","journal-title":"Oncogene"},{"issue":"11","key":"10.1016\/j.intimp.2023.110420_b0285","doi-asserted-by":"crossref","first-page":"3966","DOI":"10.1021\/acs.molpharmaceut.1c00220","article-title":"All-trans retinoic acid and doxorubicin delivery by folic acid modified polymeric micelles for the modulation of Pin1-mediated DOX-induced breast cancer stemness and metastasis","volume":"18","author":"Liu","year":"2021","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.intimp.2023.110420_b0290","article-title":"Targeting MDSC differentiation using ATRA: a phase I\/II clinical trial combining pembrolizumab and all-trans retinoic acid for metastatic melanoma","author":"Tobin","year":"2022","journal-title":"Clin. Cancer Res.: Official J. Am. Association Cancer Res."},{"issue":"sup1","key":"10.1016\/j.intimp.2023.110420_b0295","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1080\/10408398.2018.1509201","article-title":"The success and the challenge of all-trans retinoic acid in the treatment of cancer","volume":"59","author":"Ni","year":"2019","journal-title":"Crit. Rev. Food Sci. Nutr."},{"issue":"1","key":"10.1016\/j.intimp.2023.110420_b0300","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1080\/21691401.2021.1964983","article-title":"Tripterine and all-trans retinoic acid (ATRA) - loaded lipid-polymer hybrid nanoparticles for synergistic anti-arthritic therapy against inflammatory arthritis","volume":"49","author":"Li","year":"2021","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"issue":"11","key":"10.1016\/j.intimp.2023.110420_b0305","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/labinvest.2013.108","article-title":"All-transretinoic acid ameliorates bleomycin-induced lung fibrosis by downregulating the TGF-\u03b21\/Smad3 signaling pathway in rats","volume":"93","author":"Song","year":"2013","journal-title":"Lab. Invest.; J. Technical Methods Pathol."},{"issue":"2","key":"10.1016\/j.intimp.2023.110420_b0310","doi-asserted-by":"crossref","DOI":"10.1111\/dth.12455","article-title":"Retinoic acid for treatment of systemic sclerosis and morphea: a literature review","volume":"30","author":"Thomas","year":"2017","journal-title":"Dermatol. Ther."},{"issue":"5","key":"10.1016\/j.intimp.2023.110420_b0315","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.jaad.2021.10.065","article-title":"Systemic sclerosis in adults. Part I: Clinical features and pathogenesis","volume":"87","author":"Jerjen","year":"2022","journal-title":"J. Am. Acad. Dermatol."},{"issue":"2","key":"10.1016\/j.intimp.2023.110420_b0320","doi-asserted-by":"crossref","first-page":"164","DOI":"10.3109\/10837450.2013.763261","article-title":"All-trans retinoic acid-loaded lipid nanoparticles as a transdermal drug delivery carrier","volume":"19","author":"Charoenputtakhun","year":"2014","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.intimp.2023.110420_b0325","doi-asserted-by":"crossref","unstructured":"G. Zuccari, S. Baldassari, S. Alfei, B. Marengo, G.E. Valenti, C. Domenicotti, et al., D-\u03b1-tocopherol-based micelles for successful encapsulation of retinoic acid, Pharmaceuticals (Basel, Switzerland) 14 (3) (2021).","DOI":"10.3390\/ph14030212"},{"issue":"31","key":"10.1016\/j.intimp.2023.110420_b0330","doi-asserted-by":"crossref","first-page":"3703","DOI":"10.2174\/0929867325666180313110917","article-title":"Nanotechnological Advances for cutaneous release of tretinoin: an approach to minimize side effects and improve therapeutic efficacy","volume":"25","author":"Raminelli","year":"2018","journal-title":"Curr. Med. Chem."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923007439?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923007439?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T18:11:11Z","timestamp":1761588671000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576923007439"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":66,"alternative-id":["S1567576923007439"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2023.110420","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ATRA ameliorates fibrosis by suppressing the pro-fibrotic molecule Fra2\/AP-1 in systemic sclerosis","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2023.110420","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110420"}}